For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260330:nRSd6384Ya&default-theme=true
RNS Number : 6384Y Fermi Inc. 30 March 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 30, 2026
Fermi Inc.
(Exact name of registrant as specified in its charter)
Texas 001-42888 33-3560468
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
620 S. Taylor St., Suite 301 79101
Amarillo, TX
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (214) 894-7855
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 par value FRMI The Nasdaq Stock Market LLC
Common Stock, $0.001 par value FRMI The London Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. x
Item 2.02. Results of Operations and Financial Condition.
On March 30, 2026, Fermi Inc. (the "Company") issued its shareholder letter
(the "Shareholder Letter") announcing its financial results for the period
from January 10, 2025 (Inception) through December 31, 2025. The full text of
the Shareholder Letter is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein by reference. The Company is hosting a
conference call on March 30, 2026 at 8:00 am CT / 9:00 am ET to discuss its
financial results for the period from January 10, 2025 (Inception) through
December 31, 2025.
The information in this Item 2.02, including Exhibit 99.1, shall be deemed
"furnished" and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to the liabilities such section, nor shall it be deemed incorporated
by reference into any registration statement or other filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Fermi Shareholder Letter FY 2025, dated March 30, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
FERMI INC.
Date: March 30, 2026 By: /s/ Miles Everson
Name: Miles Everson
Title: Chief Financial Officer
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCKBLBXQXLXBBL
Copyright 2019 Regulatory News Service, all rights reserved